The increasing evidence supporting a role for MIF in cancer has also attracted attention on the contribution of this cytokine to the pathogenesis of glioblastoma (Figure 2) and the possible development of anti-MIF tailored treatment for this disease. Here, MIF is linked to glioblastoma.